Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase.

Marzoa-Rivas, R; Paniagua-Martín, M J; Barge-Caballero, E; Pedrosa del Moral, V; Barge-Caballero, G; Grille-Cancela, Z; Naya-Leira, C; Fariñas-Garrido, P; Blanco-Canosa, P; Mosquera, V; Castro-Beiras, A; Crespo-Leiro, M G

Marzoa-Rivas, R; Paniagua-Martín, M J; Barge-Caballero, E; Pedrosa del Moral, V; Barge-Caballero, G; Grille-Cancela, Z; Naya-Leira, C; Fariñas-Garrido, P; Blanco-Canosa, P; Mosquera, V; Castro-Beiras, A; Crespo-Leiro, M G.

Affiliation

Marzoa-Rivas R; Advanced Heart Failure and Heart Transplant Unit, Hospital Universitario A Coruña, A Coruña, Spain. Raquel.Marzoa.Rivas@sergas.es

Transplant Proc ; 42(8): 2994-6, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20970591

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Tacrolimus / Immunosuppressive Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2010 Document type: Article Affiliation country: España Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google